Keyphrases
COVID-19
92%
Acute Respiratory Distress Syndrome
87%
Bronchoalveolar Lavage
86%
Respiratory Failure
58%
Seasonal Influenza
51%
Critically Ill Patients
51%
Influenza
43%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
38%
Intubation
37%
Mechanical Ventilation
36%
Severe COVID-19
35%
Interleukin-6
34%
Lower Airways
32%
Narrative Review
32%
Severe Disease
30%
Cytokine Concentration
30%
Gram-negative Bacteria
30%
Interleukin-6 Levels
25%
COVID-19 Phenotypes
25%
Mechanically Ventilated Patients
25%
Interleukin-6 Inhibitors
25%
Respiratory Infection
25%
Pulmonary Consolidation
25%
Gram-negative
25%
Secondary Infection
25%
Extensively Drug-resistant
25%
Multidrug-resistant
25%
Young Patients
25%
Cytokine Storm
25%
Complement Activation
25%
Histoplasmosis
25%
Severe Acute Respiratory Distress Syndrome
25%
Immunocompromised Host
25%
Human Respiratory Tract
25%
Propensity Score Matching Study
25%
Human Patients
25%
Epidemiology
25%
Inflammatory Profile
25%
SARS-CoV-2 Infection
25%
Patients at Risk
25%
Respiratory Viral Infection
25%
Distinctive Features
25%
Low Risk
25%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Older Patients
25%
Obstructive Sleep Apnea
25%
Quantitative PCR
25%
Multicenter Cohort Study
25%
Emergency Department
25%
Bronchoalveolar
25%
Medicine and Dentistry
COVID-19
100%
Lung Lavage
94%
Acute Respiratory Distress Syndrome
80%
Severe Acute Respiratory Syndrome Coronavirus 2
72%
Infection
67%
Respiratory Failure
57%
Cytokine
54%
Seasonal Influenza
51%
Diseases
38%
Extracorporeal Membrane Oxygenation
34%
Interleukin 6
33%
Diagnosis
33%
Artificial Respiration
33%
Intubation
31%
Outpatient
29%
Steady State
25%
Complement Activation
25%
Reverse Transcription Polymerase Chain Reaction
25%
Respiratory Tract Infection
25%
Pulmonary Consolidation
25%
Emergency Department
25%
Pneumocystis Pneumonia
25%
Viral Respiratory Tract Infection
25%
Gram-Negative Bacteria
25%
Receptor Blocking Agent
25%
Secondary Infection
25%
Cytokine Storm
25%
Interleukin 6 Receptor
25%
Antimicrobial Therapy
25%
Immunocompromised Patient
25%
Itraconazole
25%
Computer Assisted Tomography
25%
Broad-Spectrum Antibiotic
25%
Dyspnea
25%
Lung Biopsy
25%
Lobar Pneumonia
25%
Uveitis
25%
Methotrexate
25%
Coughing
25%
Nasopharyngeal Swab
22%
Lung
18%
Hypoxemia
17%
Immune Response
16%
Bronchoscopy
16%
Ventilator Induced Lung Injury
12%
Tocilizumab
12%
Antiinfective Agent
10%
Pathogen
10%
Antibiotic Resistance
10%
Immune Dysregulation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
72%
SARS Coronavirus
72%
Diseases
56%
Cytokine
54%
Coronavirinae
51%
Adult Respiratory Distress Syndrome
51%
Respiratory Failure
36%
Interleukin 6
33%
Pseudomonas aeruginosa
25%
Interleukin 6 Receptor
25%
Secondary Infection
25%
Pseudomonas Infection
25%
Seasonal Influenza
25%
Acute Kidney Failure
25%
Cytokine Storm
25%
Receptor Blocking Agent
25%
Sleep Disordered Breathing
25%
Respiratory Tract
25%
Viral Respiratory Tract Infection
25%
Endothelium Injury
17%
Hypercoagulability
17%
Tocilizumab
12%
Immune Dysregulation
10%
Intubation
9%
Alpha 2 Macroglobulin
8%
Thrombomodulin
8%
Von Willebrand Factor
8%
Immunoglobulin
8%
Critical Illness
8%
Antibodies
8%
Angiopoietin 2
8%
Immunoglobulin A
8%
Immunoglobulin M
8%
Clinical Trial
8%
Acute Respiratory Failure
8%
Drug Discovery
8%
Pathophysiology
5%
Virus Infection
5%
Lung Disease
5%
Amoxicillin
5%
Leukocyte Antigen
5%
Combination Therapy
5%
Cystic Fibrosis
5%
Antimicrobial Resistance
5%
Infectious Agent
5%
Antimicrobial Therapy
5%
RANTES
5%
Flow Cytometry
5%
Immunocompromised Patient
5%
Homo sapiens
5%